Novo Nordisk A/S is prepared for potential tariffs from US President Donald Trump, the Danish drugmaker’s chief executive ...

We recently published an article titled Jim Cramer’s Game Plan: 15 Stocks in Focus. In this article, we are going to take a ...

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

Ved udgangen af 2024 havde Novo Nordisk 34.185 ansatte her i landet. Dermed steg selskabets danske beskæftigelse med knap ...

Hos Sydbank hæfter senioranalytiker Søren Løntoft Hansen ved den ”meget stærke vækst”, som Novo Nordisk præsenterede i sit ...

Novo Nordisk said on Thursday it has not yet posted details about a new trial of its experimental next-generation obesity drug CagriSema, which it announced it would start after late-stage trial data ...

J&J, AstraZeneca, Novo Nordisk and Roche are among the companies that might take a hit from the soon-to-be-enacted fees, ...

Stocks to Buy or Sell. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other stocks to buy and sell highlighted in Jim Cramer’s latest calls. Jim ...

Novo Nordisk (NVO), the maker of the popular GLP-1 medications Wegovy and Ozempic, said potential tariffs on Europe imposed ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE ... and his much-feared tariffs against Canada and Mexico might also not realize as the new administration said it ...

Novo Nordisk skal dermed sætte et loft på 35 amerikanske dollars ... Eksempelvis alternativer fra Mexico, som også er blevet ramt af den amerikanske told på 25 procent. Donald Trump underskrev lørdag ...

The Novo Nordisk Foundation does not plan to step in to prop up a global health sector reeling from a freeze on U.S.-funded ...